MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2026 International Congress

    Impact of a Structured Patient Education Module on Knowledge of Botulinum Toxin Therapy, Goal Attainment, and Treatment Satisfaction in Cervical Dystonia

    K. Katawatee, R. Bhidayasiri, P. Panyakaew (Bangkok, Thailand)

    Objective: To evaluate the impact of a structured patient education program on knowledge and goal attainment, measured by the structured Goal Attainment Scale (GAS), following…
  • 2025 International Congress

    Precision Management of Oromandibular Dystonia (OMD): The Role of Neurological examination, Electromyographic (EMG) Guidance, and Odontological evaluation (OE) – A descriptive study with a Multidisciplinary Approach for Botulinum Toxin A (BoNT/A) Treatment

    A. Stark, H. Biernat, K. Benedek, P. Mcgettigan, M. Bakke, A. Lokkegaard (Rsokilde, Denmark)

    Objective: To demonstrate the advantages of OE, when facing challenges with identifying patterns of OMD for employment of EMG for guided BoNT/A precision management. Background:…
  • 2025 International Congress

    Use of Botulinum Toxin Application in the Inferior Oblique Capitis Muscle Under Tomographic Guidance in Cervical Dystonia Report of Two Cases

    I. Amorín, A. Rodriguez, N. Sorondo, B. Cardozo (Montevideo, Uruguay)

    Objective: To communicate the advantages of botulinum toxin application for dystonia under tomographic guidance in cervical muscles applying the Col/Cap concept. Background: The first case…
  • 2025 International Congress

    Long-Term Therapeutic Effect of Botulinum Neurotoxin Type A (BoNT-A) in Cervical Dystonia: A Case Series.

    R. Lopez-Castellanos, R. Lopez-Contreras (Boston, USA)

    Objective: To evaluate the long-term therapeutic effect of Botulinum neurotoxin type A (BoNT-A) in cervical dystonia. Background: Cervical dystonia is the most common adult-onset focal…
  • 2025 International Congress

    Development and Testing of a Smartphone Application to Capture Patient-Centered Outcome (PCO) Measures for Dystonia

    P. Reyes, A. Tingin, B. Berman, S. Schneider, J. Hieshetter, K. Kuman, G. Kilic-Berkmen, L. Wright, F. Qeadan, J. Perlmutter, H. Jinnah, S. Pirio-Richardson (Richmond, USA)

    Objective: Develop a smartphone application to collect patient-centered outcome (PCO) measures for dystonia. Background: PCO measures tailored for each major adult-onset focal dystonia subtype (Cervical…
  • 2025 International Congress

    Characteristics of IncobotulinumtoxinA Treatment for Cervical Dystonia in a Real-World Setting: Dosing and Muscles Injected

    J. Holmes, A. Kong, G. Askin, D. Nomah, D. Joseph, K. Biney, M. Hast (Raleigh, USA)

    Objective: To describe incobotulinumtoxinA doses and muscles injected in a real-world setting for patients with cervical dystonia (CD) Background: IncobotulinumtoxinA is approved to treat CD…
  • 2025 International Congress

    Blepharospasm as cause of facial pain and “sinus” headache: A case series

    J. Anang (Winnipeg, Canada)

    Objective: Describe the clinical spectrum of blepharospasm Background: Blepharospasm is characterized by stereotyped, bilateral and synchronous spasms of the orbicularis oculi muscles Method: Case report…
  • 2025 International Congress

    Telehealth Follow-up for Craniofacial Dystonias Treated with Neurotoxin Injection: Physician Outcomes

    K. Harper, L. Kopaeva, L. Venditti, J. Meystedt, M. Hacker, S. Sharp, P. Charles (Nashville, USA)

    Objective: To evaluate the potential benefits of a post-injection telehealth follow-up visit for people with craniofacial dystonia. Background: Craniofacial dystonias, including blepharospasm and oromandibular dystonia,…
  • 2025 International Congress

    Delayed Diagnosis of Cervical Dystonia: A Case Report Highlighting the Importance of an on-time Specialist Evaluation

    A. Lysandropoulos (Durham, USA)

    Objective: To present a case of cervical dystonia misdiagnosed as anxiety disorder for five years, emphasizing the critical need for timely recognition and appropriate treatment…
  • 2025 International Congress

    Dystonia in Cameroon: Clinical characteristic and treatment patterns

    HD. Ewodo Touna, D. Gams Massi, M A. Magnerou, C. Kenmegne, E. Chokote, E. Gueumekane Bila, M. Tonga, D. Atsa Kouda, G. Nokam, Y. Mapoure Njankouo (Douala, Cameroon)

    Objective: To describe the clinical characteristics and treatment patterns of dystonia in a cohort of Cameroonian patients. Background: Dystonia is a complex and heterogeneous movement…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 23
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley